ALDH1A1 and neoplasm: Finally, increasing evidence indicates that higher percentage of ALDH1 positive tumor cells may serve as a novel prognostic marker associated with poor clinical outcome in multiple human solid cancers including breast [34], [37], [42], lung [38], pancreatic [40], bladder [41] and prostate [43] cancers.